文献速递生殖医学

piRNA通路因子新纯合变异导致人类男性不育

Novel homozygous variants in piRNA pathway factors lead to male infertility in humans.
PubMed 文献 · Reprod Biomed Online · 2025-03-22

本研究对592例特发性不育男性行全外显子组和Sanger测序,在4个无关家系中检出TDRD9、HENMT1和EXD1的纯合变异,其中EXD1终止获得性变异为首次报道;一例EXD1 affected个体经ICSI获得活产。

要点

  • 在592例特发性不育男性中检出TDRD9、HENMT1和EXD1纯合变异。
  • EXD1终止获得性变异首次与男性不育相关,ICSI显示潜在疗效。
  • 结果为男性不育的遗传咨询和潜在临床治疗提供理论依据。

核心结论

  • 在TDRD9、HENMT1和EXD1中检出新的纯合变异,拓宽了男性不育的piRNA相关遗传谱。
  • EXD1终止获得性变异首次与男性不育相关,ICSI显示潜在疗效。
  • 为这些患者的遗传咨询和潜在临床治疗提供理论依据。

研究设计与样本

  • 对592例特发性不育男性行全外显子组测序和Sanger测序,以识别和验证与精子发生相关的潜在有害变异。
  • 采用体外实验验证变异对蛋白表达的影响。
  • 通过苏木精-伊红染色、免疫荧光和小RNA测序评估候选基因变异的功能效应。
  • 对EXD1 affected个体行卵胞浆内单精子注射(ICSI)。

主要发现

  • 在4个无关家系的不育男性中检出3个对piRNA生成至关重要的基因的纯合变异。
  • 两名患者分别检出TDRD9纯合错义变异(c.3587T>C,p.L1196P)和纯合移码变异(c.179_186del,p.Q61Gfs*22)。
  • 携带TDRD9移码变异的患者表现为精子发生不完全停滞和部分减数分裂缺陷。
  • 一名患者检出HENMT1纯合移码变异(c.47_75del,p.F16Sfs*3),其睾丸组织piRNA丰度降低。
  • 上述三名患者被诊断为非梗阻性无精子症。

临床怎么用

  • 作者认为EXD1终止获得性变异与男性不育相关,ICSI显示潜在疗效,提示其潜在效用值得在更大队列中进一步研究。
  • 作者认为本研究为这些患者的遗传咨询和潜在临床治疗提供了理论依据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Given the association between abnormal PIWI-interacting RNA (piRNA) biogenesis and human male infertility, are there novel variants of genes involved in the piRNA pathway responsible for human azoospermia or oligozoospermia? DESIGN: Whole-exome sequencing and Sanger sequencing were performed to identify and validate potential deleterious variants associated with spermatogenesis in a cohort of 592 idiopathic infertile men. The impact of variants on protein expression was validated using in-vitro experiments. The functional effects of the candidate gene variants were evaluated by haematoxylin and eosin staining, immunofluorescence and small RNA sequencing. Intracytoplasmic sperm injection (ICSI) was performed in the EXD1-affected individual. RESULTS: Homozygous variants in three genes crucial for piRNA biogenesis were identified in infertile men from four unrelated families. Notably, a homozygous missense variant (c.3587T>C, p.L1196P) and a homozygous frameshift variant (c.179_186del, p.Q61Gfs*22) in TDRD9 were identified in two patients. The patient carrying the frameshift variant in TDRD9 exhibited incomplete arrest of spermatogenesis and partial meiotic defects. In addition, a homozygous HENMT1 frameshift variant (c.47_75del, p.F16Sfs*3) was identified in one patient whose testicular tissue showed reduced abundance of piRNA. These three patients were diagnosed with non-obstructive azoospermia. Finally, the fourth patient harboured the first reported loss-of-function variant of EXD1 (c.550C>T, p.R184*), and exhibited oligoasthenoteratozoospermia characterized by acrosomal hypoplasia; ICSI treatment in this case resulted in a live birth, suggesting its potential utility for further investigation in larger cohorts. CONCLUSIONS: Novel homozygous variants were identified in TDRD9, HENMT1 and EXD1, broadening the piRNA-related genetic spectrum in male infertility. EXD1 stop-gain variant was linked to male infertility for the first time, with ICSI showing potential efficacy. This provides a theoretical basis for genetic counselling and potential clinical treatment of these patients.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Hu K, Sha X, Zu C, et al. Novel homozygous variants in piRNA pathway factors lead to male infertility in humans. Reprod Biomed Online. 2025. PMID: 40645105. doi:10.1016/j.rbmo.2025.104974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。